| Product Type: | Recombinant Rabbit monoclonal IgG, primary antibodies |
|---|---|
| Species reactivity: | Human, Mouse |
| Applications: | IF-Tissue, IF-Cell, FC |
| Clonality: | Monoclonal |
| Clone number: | SU0338 |
| Form: | Liquid |
| Storage condition: | Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term. |
| Storage buffer: | Preservative: 0.02% Sodium azide Constituents: 30% Glycerol, 1% BSA, 68.98% PBS. |
| Concentration: | 1ug/ul |
| Purification: | Protein A affinity purified. |
| Molecular weight: | Predicted band size: 54 kDa |
| Isotype: | IgG |
| Immunogen: | Synthetic peptide within Human Cytokeratin 8 aa 321-370 / 483. |
| Positive control: | Human breast tissue, human liver tissue, SK-Br-3, A431. |
| Subcellular location: | Nucleoplasm, Nucleus matrix, Cytoplasm. |
| Recommended Dilutions:
IF-Tissue IF-Cell FC |
1:100-1:400 1:50 1:500-1:1,000 |
| Uniprot #: | SwissProt: P05787 Human | P11679 Mouse |
| Alternative names: | CARD2 Cell proliferation inducing gene 46 protein Cell proliferation inducing protein 46 CK 8 CK-8 CK8 CYK8 Cytokeratin 8 Cytokeratin-8 K2C8 K2C8_HUMAN K8 Keratin 8 Keratin keratin type II cytoskeletal 8 Keratin-8 KRT8 type II cytoskeletal 8 Type-II keratin Kb8 |
|
Fig1:
Immunofluorescence analysis of paraffin-embedded human breast tissue labeling Cytokeratin 8 (HA720118F). The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Cytokeratin 8 (HA720118F, red) at 1/400 dilution at +4℃ overnight, washed with PBS. Nuclei were counterstained with DAPI (blue). |
|
Fig2:
Immunofluorescence analysis of paraffin-embedded human liver tissue labeling Cytokeratin 8 (HA720118F) and Vimentin (EM0401). The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Cytokeratin 8 (HA720118F, red) at 1/100 dilution and Vimentin (EM0401, green) at 1/400 dilution at +4℃ overnight, washed with PBS. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) were used as the secondary antibody at 1/1,000 dilution. Nuclei were counterstained with DAPI (blue). |
|
Fig3:
Immunocytochemistry analysis of SK-Br-3 cells labeling Cytokeratin 8 (HA720118F). Cells were fixed in methanol and then blocked with 2% negative goat serum for 15 minutes at room temperature. The cells were then incubated overnight at +4℃ with Cytokeratin 8 (HA720118F, red) at 1/50 dilution and Beta-tubulin (EM0103, yellow) at 1/400 dilution. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) were used as the secondary antibody at 1/1,000 dilution. Nuclei were counterstained with DAPI (blue). |
|
Fig4:
Flow cytometric analysis of A431 cells labeling Cytokeratin 8. Cells were fixed and permeabilized. Then incubated for 1 hour at +4℃ with Cytokeratin 8 (HA720118F, red, 1ug/ml) and Rabbit IgG Isotype Control (iFluor™ 488, green, 1ug/ml). Unlabelled sample was used as a control (cells without incubation with primary antibody; black). |